PE Ratio
2.81
-0.19-6.33%
Fri, 07 Feb 2025 21:00:00 GMT
Summary
- As of February 8, 2025, PMCB price to earnings ratio is 2.81, with a fall of -0.19 (-6.33%) during the most recent trading day.
- PMCB PE ratio is now -21.51% below its all-time high of 3.58.
Performance
PMCB PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PE Ratio Formula
P/E = Price
TTM Earnings Per Share
Price
TTM Earnings Per Share
TTM Earnings Per Share
PMCB PE Ratio Trends
PeriodPeriod | PE ratioPE ratio | PricePrice | TTM EPSTTM EPS | TTM revenueTTM revenue |
---|---|---|---|---|
todaytoday | -6.3% | -6.3% | -19.7% | - |
1 m1 month | -10.2% | -10.2% | - | - |
3 m3 months | -20.4% | -20.3% | 0.0% | - |
6 m6 months | -2.8% | -21.8% | - | - |
ytdytd | -5.1% | -5.1% | - | - |
1 y1 year | - | -31.3% | 0.0% | - |
5 y5 years | - | -98.3% | +303.9% | - |
PMCB PE Ratio Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -13.5% | 2.79 | +0.7% | |
3 m | 3-month | 3.57 | -21.3% | 2.79 | +0.7% |
6 m | 6-month | 3.58 | -21.5% | 2.15 | +30.7% |
1 y | 1-year | 3.58 | -21.5% | 2.15 | +30.7% |
3 y | 3-year | 3.58 | -21.5% | 2.15 | +30.7% |
5 y | 5-year | 3.58 | -21.5% | 2.15 | +30.7% |
alltime | all time | 3.58 | -21.5% | 2.15 | +30.7% |
PharmaCyte Biotech PE Ratio History
Date | Value |
---|---|
2025 | 2.81(-5.1%) |
Date | Value |
---|---|
2024 | 2.96 |
FAQ
- What is PharmaCyte Biotech price to earnings ratio?
- What is the all time high PE ratio for PharmaCyte Biotech?
- What is PMCB price to earnings ratio year-to-date change?
What is PharmaCyte Biotech price to earnings ratio?
The current PE ratio of PMCB is 2.81
What is the all time high PE ratio for PharmaCyte Biotech?
PharmaCyte Biotech all-time high price to earnings ratio is 3.58
What is PMCB price to earnings ratio year-to-date change?
PharmaCyte Biotech price to earnings ratio has changed by -0.15 (-5.07%) since the beginning of the year